Bifogade filer
Coloplast CMD 2025 invitation
Kurs
-1,09%
Likviditet
140 MDKK
Kalender
| Est. tid* | ||
| 2025-12-04 | N/A | Årsstämma |
| 2025-11-04 | 12:10 | Bokslutskommuniké 2025 |
| 2025-08-19 | 07:30 | Kvartalsrapport 2025-Q3 |
| 2025-05-06 | - | Kvartalsrapport 2025-Q2 |
| 2025-02-04 | - | Kvartalsrapport 2025-Q1 |
| 2024-12-06 | - | X-dag halvårsutdelning COLO B 17 |
| 2024-12-05 | - | Årsstämma |
| 2024-11-05 | - | Bokslutskommuniké 2024 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q3 |
| 2024-05-13 | - | X-dag halvårsutdelning COLO B 5 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q2 |
| 2024-02-09 | - | Kvartalsrapport 2024-Q1 |
| 2023-12-08 | - | X-dag halvårsutdelning COLO B 16 |
| 2023-12-07 | - | Årsstämma |
| 2023-11-09 | - | Bokslutskommuniké 2023 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-05-15 | - | X-dag halvårsutdelning COLO B 5 |
| 2023-05-11 | - | Kvartalsrapport 2023-Q2 |
| 2023-02-03 | - | Kvartalsrapport 2023-Q1 |
| 2022-12-02 | - | X-dag halvårsutdelning COLO B 15 |
| 2022-12-01 | - | Årsstämma |
| 2022-11-07 | - | Bokslutskommuniké 2022 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q3 |
| 2022-05-09 | - | X-dag halvårsutdelning COLO B 5 |
| 2022-05-05 | - | Kvartalsrapport 2022-Q2 |
| 2022-01-25 | - | Kvartalsrapport 2022-Q1 |
| 2021-12-03 | - | X-dag halvårsutdelning COLO B 14 |
| 2021-12-02 | - | Årsstämma |
| 2021-11-01 | - | Bokslutskommuniké 2021 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q3 |
| 2021-05-10 | - | X-dag halvårsutdelning COLO B 5 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q2 |
| 2021-02-06 | - | Kvartalsrapport 2021-Q1 |
| 2020-12-04 | - | X-dag halvårsutdelning COLO B 13 |
| 2020-12-03 | - | Årsstämma |
| 2020-11-03 | - | Bokslutskommuniké 2020 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q3 |
| 2020-05-11 | - | X-dag halvårsutdelning COLO B 5 |
| 2020-05-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-02-06 | - | Kvartalsrapport 2020-Q1 |
| 2019-12-06 | - | X-dag halvårsutdelning COLO B 12 |
| 2019-12-05 | - | Årsstämma |
| 2019-11-05 | - | Bokslutskommuniké 2019 |
| 2019-08-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-05-06 | - | X-dag halvårsutdelning COLO B 5 |
| 2019-05-02 | - | Kvartalsrapport 2019-Q2 |
| 2019-02-05 | - | Kvartalsrapport 2019-Q1 |
| 2018-12-06 | - | X-dag halvårsutdelning COLO B 11 |
| 2018-12-05 | - | Årsstämma |
| 2018-11-01 | - | Bokslutskommuniké 2018 |
| 2018-08-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-05-07 | - | X-dag halvårsutdelning COLO B 5 |
| 2018-05-03 | - | Kvartalsrapport 2018-Q2 |
| 2018-02-01 | - | Kvartalsrapport 2018-Q1 |
| 2017-12-08 | - | X-dag halvårsutdelning COLO B 10.5 |
| 2017-12-07 | - | Årsstämma |
| 2017-11-02 | - | Bokslutskommuniké 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-05-08 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2017-05-03 | - | Kvartalsrapport 2017-Q2 |
| 2017-02-01 | - | Kvartalsrapport 2017-Q1 |
| 2016-12-06 | - | X-dag halvårsutdelning COLO B 9 |
| 2016-12-05 | - | Årsstämma |
| 2016-11-02 | - | Bokslutskommuniké 2016 |
| 2016-08-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-05-09 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2016-05-03 | - | Kvartalsrapport 2016-Q2 |
| 2016-02-02 | - | Kvartalsrapport 2016-Q1 |
| 2015-12-10 | - | X-dag halvårsutdelning COLO B 8 |
| 2015-12-09 | - | Årsstämma |
| 2015-11-03 | - | Bokslutskommuniké 2015 |
| 2015-08-11 | - | Kvartalsrapport 2015-Q3 |
| 2015-05-07 | - | X-dag halvårsutdelning COLO B 4.5 |
| 2015-05-05 | - | Kvartalsrapport 2015-Q2 |
| 2015-01-29 | - | Kvartalsrapport 2015-Q1 |
| 2014-12-05 | - | X-dag halvårsutdelning COLO B 7.5 |
| 2014-12-04 | - | Årsstämma |
| 2014-10-30 | - | Bokslutskommuniké 2014 |
| 2014-05-08 | - | X-dag halvårsutdelning COLO B 4 |
| 2013-12-06 | - | X-dag halvårsutdelning COLO B 7 |
| 2013-12-05 | - | Årsstämma |
| 2013-10-31 | - | Bokslutskommuniké 2013 |
| 2013-08-13 | - | Kvartalsrapport 2013-Q3 |
| 2013-05-06 | - | X-dag halvårsutdelning COLO B 3 |
| 2013-04-30 | - | Kvartalsrapport 2013-Q2 |
| 2013-01-30 | - | Kvartalsrapport 2013-Q1 |
| 2012-12-19 | - | Split COLO B 1:5 |
| 2012-12-11 | - | Årsstämma |
| 2012-11-06 | - | Bokslutskommuniké 2012 |
| 2012-08-15 | - | Kvartalsrapport 2012-Q3 |
| 2012-04-26 | - | Kvartalsrapport 2012-Q2 |
| 2012-01-25 | - | Kvartalsrapport 2012-Q1 |
| 2011-12-08 | - | X-dag ordinarie utdelning COLO B 14.00 DKK |
| 2011-12-07 | - | Årsstämma |
| 2011-11-01 | - | Bokslutskommuniké 2011 |
| 2011-08-17 | - | Kvartalsrapport 2011-Q3 |
| 2011-06-21 | - | Kapitalmarknadsdag 2011 |
| 2011-05-04 | - | Kvartalsrapport 2011-Q2 |
| 2011-01-26 | - | Kvartalsrapport 2011-Q1 |
| 2010-12-02 | - | X-dag ordinarie utdelning COLO B 10.00 DKK |
| 2009-12-02 | - | X-dag ordinarie utdelning COLO B 7.00 DKK |
| 2004-12-16 | - | Split COLO B 1:2 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)
Ellehammersvej 20, 2770 Kastrup
from 10.30 - 17.00 CEST
(Central European Summer Time)
Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.
The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.
The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.
The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).
The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.
Agenda in CEST
10.00 - 10.30 Registration
10.30 - 12.30 Plenary session: Group strategy and financials, strategy for Chronic Care and Voice and Respiratory Care
12.30 - 13.00 Lunch break
13.00 - 17.00 Q&A breakout sessions (incl. breaks)
17.00 - 18.30 Social activity (on premise)
Coloplast representatives
Plenary session:
Lars Rasmussen, Interim President and CEO
Anders Lonning-Skovgaard, Executive Vice President, CFO
Nicolai Buhl, Executive Vice President, Chronic Care
Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care
Breakout sessions:
Chronic Care deep dive:
Mike DelVacchio, Senior Vice President, North America
Thomas Bruhn, Senior Vice President, Emerging Markets
Advanced Wound Care:
Fertram Sigurjonsson, Founder and President, Kerecis
Bernd Greiner, Senior Vice President, Adv. Wound Dressings
Interventional Urology:
Thomas NP Johns Jr, Executive Vice President, Interventional Urology
Global Operations and People & Culture:
Allan Rasmussen, Executive Vice President, Global Operations
Dorthe Rønnau, Executive Vice President, People & Culture
In-person participation
If you wish to join us in-person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to CMD2025@coloplast.com stating your full name, company, contact phone number and itinerary (if relevant).
Kindly register before Friday, 15 August 2025.
Virtual participation
Virtual participation will be possible for the plenary session.
A link for the webcast of the plenary sessions will be available on our website closer to the date.
For more information,
please contact:
Aleksandra Dimovska, Vice President
Direct tel.: +45 4911 2458
E-mail: dkadim@coloplast.com
Simone Dyrby Helvind, Sr. Manager
Direct tel.: +45 4911 2981
E-mail: dksdk@coloplast.com
Julie Sommer Müggler, Coordinator
Direct tel.: +45 4911 3161
Email: dkjusm@coloplast.com